Symbotic Inc (SYM)

NASDAQIndustrialsIndustrial - MachinerySnapshot 2026-10-23

$39.28-2.68%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Symbotic Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	$760M–$780M	—
EBITDA	$100M–$105Mnon-GAAP	—
FY 2027 · Q1
Revenue	—	818.34M
EPS	—	0.073
FY 2027 · Annual
Revenue	—	3.59B
EPS	—	0.411
FY 2028 · Annual
Revenue	—	4.52B
EPS	—	0.846

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Adjusted EBITDA expands with profitability	Profitability expands with rising adjusted EBITDA.	Improving	EBITDA margin contracts meaningfully below recent levels	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Adjusted EBITDA increased from $35 million in 2025-Q2 to $95 million in 2026-Q2, while operating income improved from a loss of $36.6 million in 2025-Q3 to a positive $6.1 million in 2026-Q2. The trajectory shows delivering significant profitability expansion consistent with management's focus. Delivery assessment Oct 24, 2026
Cash from operations improves to about $261M in 2026-Q2	Cash from operations improves from $191M to $261M in two quarters.	Intact	Cash from operations falls below $200 million in 2026-Q2	Cash from operations: $-147.297M FY2026-Q3; GAAP. Published target: >= $260 million. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Source published Aug 5, 2026-147,297,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 27, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Cash from operating activities was $531 million in 2025-Q4 but declined to $261 million in 2026-Q2. Despite management's focus, cash flow shows a declining trajectory this period, indicating limited progress on improving cash generation. Delivery assessment Oct 24, 2026
Revenue grows to about $710M in Q3 2026	A primary condition in Symbotic Inc's published investment case. The stated target is >= $710 million.	Intact	Revenue falls below $600 million in 2026-Q3	Revenue: $720.838M FY2026-Q3; GAAP. Published target: >= $710 million. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 5, 2026720,838,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 27, 2026 Source: company_financial_results. Reference: d6967fc8-2978-420e-ae70-df05b62b3ad0. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue increased from $592 million in 2025-Q4 to $721 million in 2026-Q2, supported by systems in deployment rising from 70 to 77 over 2026-Q1 to 2026-Q2. The trajectory is delivering consistent growth aligned with management's stated focus. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-09-27 · fmp

FY2028 EPS$0.85

$0.83 → $0.85 · observed estimates

FY2028 revenue$4.52B

$4.51B → $4.52B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-09-28	$0.83	$4,509,787,999	5 / 9
2026-09-29	$0.83	$4,509,787,999	5 / 9
2026-09-30	$0.83	$4,509,787,999	5 / 9
2026-10-01	$0.83	$4,509,787,999	5 / 9
2026-10-02	$0.83	$4,509,787,999	5 / 9
2026-10-03	$0.83	$4,509,787,999	5 / 9
2026-10-04	$0.83	$4,509,787,999	5 / 9
2026-10-05	$0.83	$4,509,787,999	5 / 9
2026-10-06	$0.83	$4,509,787,999	5 / 9
2026-10-07	$0.83	$4,509,787,999	5 / 9
2026-10-08	$0.83	$4,509,787,999	5 / 9
2026-10-09	$0.83	$4,509,787,999	5 / 9
2026-10-10	$0.83	$4,509,787,999	5 / 9
2026-10-11	$0.83	$4,509,787,999	5 / 9
2026-10-12	$0.83	$4,509,787,999	5 / 9
2026-10-13	$0.86	$4,509,787,999	5 / 9
2026-10-14	$0.86	$4,509,787,999	5 / 9
2026-10-15	$0.86	$4,510,104,048	5 / 9
2026-10-16	$0.86	$4,510,104,048	5 / 9
2026-10-17	$0.86	$4,510,104,048	5 / 9
2026-10-18	$0.86	$4,510,104,048	5 / 9
2026-10-19	$0.86	$4,510,104,048	5 / 9
2026-10-20	$0.86	$4,510,104,048	5 / 9
2026-10-21	$0.86	$4,510,104,083	6 / 10
2026-10-22	$0.86	$4,510,104,083	6 / 10
2026-10-23	$0.85	$4,521,751,621	6 / 10
2026-10-24	$0.85	$4,521,751,621	7 / 11

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	10	7	3
2026-06-01	10	7	3
2026-07-01	10	6	3
2026-08-01	10	5	3
2026-09-01	10	5	3
2026-10-01	9	5	3

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 9 Buy / Strong Buy · 5 Hold · 3 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Adjusted EBITDA expands with profitabilityDirect metric needs a verified mapping
Cash from operations improves to about $261M in 2026-Q2Cash from operations: $-147.297M
Revenue grows to about $710M in Q3 2026Revenue: $720.838M

Next proof point

Nov 23, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.5%Typical daily move · historical

Downside history

-56.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Symbotic Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This investment represents a long-term thesis on a company that is currently loss-making but has stable management. The thesis is in a watch state, as recent performance has been neutral and below industry peers.

What's priced into Symbotic Inc

The market currently prices SYM at a premium compared to its peers, indicating that investors expect strong future performance. However, there is an expectations gap, suggesting that some of these high expectations may not be fully justified given the company's recent challenges.

What the fundamentals likely do

Management is focused on revenue growth and improving profitability, with recent results showing positive trends in these areas. However, cash flow from operations has declined, indicating some challenges in generating cash, which could impact future performance.

What Symbotic Inc hinges on

The future performance of SYM will depend on sector momentum, particularly the performance of key industry players like GEV, PH, and TT. Additionally, any changes in guidance from SYM could significantly affect market perceptions and stock performance.

Bottom line

Over the next 1 to 3 years, SYM's trajectory will largely depend on its ability to navigate sector headwinds and improve cash generation. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.